trending Market Intelligence /marketintelligence/en/news-insights/trending/sjau9qijar1uufyqashkcg2 content esgSubNav
In This List

MeiraGTx closes $75M IPO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


MeiraGTx closes $75M IPO

MeiraGTx Holdings PLC closed its IPO to raise gross proceeds of $75 million.

The New York-based MeiraGTx sold 5 million ordinary shares at $15 per share.

The gene therapy company's ordinary shares started trading on the Nasdaq Global Select Market on June 8 under the ticker symbol MGTX.

Bank of America Merrill Lynch, Barclays and Evercore ISI acted as joint book-running managers for the offering, with Chardan as lead manager.